Patent · US Active

Pyrazolo[1,5-a]pyrazin-4-yl derivatives

US11472809B2 · kind B2 · utility

0Cited by

1References

4Claims

0Family size

Assignee

PFIZER INC. · US

Inventors

Matthew Frank Brown · Stonington, US
Alpay Dermenci · East Lyme, US
Andrew Fensome · Wayne, US
Brian Stephen Gerstenberger · Brookline, US
Matthew Merrill Hayward · Old Lyme, US
Dafydd Rhys Owen · Concord, US
Stephen Wayne Wright · Old Lyme, US
Li Xing · Lexington, US
Xiaojing Yang · Waterford, US

Key dates

Filing date	Sep 8, 2020
Grant date	Oct 18, 2022
Priority date	—
Expiry date	Sep 8, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

There is a method for treating a psoriasis. A compound is administered in a therapeutically effective amount to a subject suffering therefrom. The compound has the structure or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable solvate thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.